About Greatbatch, Inc.Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com.
Greatbatch, Inc. today announced it will establish a new global headquarters in Frisco, Texas, as part of the company’s continued approach to advance its medical device strategy. Over the past several years, Greatbatch has grown to more than 20 locations worldwide as part of its corporate growth strategy, which will include entry into emerging markets in Asia. Relocating its global headquarters will put Greatbatch at the center of a vibrant medical device community with a strong business climate, as well as offer convenient access to an international airport that will more readily connect the company to its global locations and customers. “The Dallas-Ft. Worth metro area is a recognized medical device cluster surrounded by a business community that includes leading medical technology and electronics firms, as well as academic research institutions and industry opinion leaders,” said Thomas J. Hook, President and CEO of Greatbatch, Inc. “While we anticipate expanding our presence at the new headquarters location in the years ahead, we also remain firmly committed to our more than 700 associates in Western New York, as well as the local community. The high-quality work of our Western New York associates is vital to our future and our Associates here will remain an integral part of Greatbatch’s success.” The company will continue to maintain existing corporate, R&D and manufacturing functions in Western New York and does not plan any changes to the existing employee base. In recent years, Greatbatch has intensified its focus on driving revenue and profitable growth in its core business, identifying and growing through targeted acquisitions, and innovating new medical device technologies. The new headquarters decision is one of several moves that Greatbatch has made since 2008 to execute its strategy to become a leading medical technology company. The first phase of the headquarters move will begin this summer with the relocation of some members of the Greatbatch Executive Leadership Team to the Frisco area. Future phases will be considered as business needs warrant.